申请人:Hoffmann-La Roche Inc.
公开号:US20140155602A1
公开(公告)日:2014-06-05
The present invention relates to ethynyl compounds of formula I-C1
wherein
R
1
, R
2
, R
2′
, R
3
, R
3′
, R
6
, U, V and W are as defined herein and to a pharmaceutically acceptable acid addition salts, to a racemic mixtures, or to its corresponding enantiomers and/or optical isomers and/or stereoisomers thereof, which are allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5).
本发明涉及公式I-C1的乙炔基化合物,其中R1、R2、R2'、R3、R3'、R6、U、V和W如本文所定义,并涉及其对应的手性异构体和/或光学异构体和/或立体异构体的药学上可接受的酸加成盐,它们是代谢型谷氨酸受体亚型5(mGluR5)的变构调节剂。